Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using Pharyngeal Electrostimulation to Treat Swallowing Difficulties from Neurological Conditions

Official title: Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia

Run by Karl Landsteiner University of Health Sciences · NCT05190718 · Data updated 2026-11-12

This study is testing a new device called Phagenyx® to see if it can help people with swallowing difficulties caused by neurological conditions like stroke or brain injury.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorKarl Landsteiner University of Health Sciences
Academic / other
Locations1 site (Tulln, Low Austria)
StatusRecruiting
StartedDecember 15, 2021
Main results expectedDecember 1, 2025
Study endsDecember 30, 2026
Registry record updatedMarch 7, 2025
Trial IDNCT05190718 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with neurogenic dysphagia resulting from conditions like stroke, traumatic brain injury, or Parkinson's disease.

Probably not a fit

Patients with unstable cardiac or respiratory conditions, or those who are pregnant or breastfeeding, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the implementation of pharyngeal electrostimulation therapy for patients suffering from neurogenic dysphagia, a condition often resulting from neurological diseases such as stroke, traumatic brain injury, and long COVID-19. The study aims to evaluate the effectiveness of the Phagenyx® device, which has shown promise in improving swallowing function in patients who are difficult to treat with conventional methods. Participants will undergo standardized assessments to determine their eligibility and the impact of the therapy on their swallowing capabilities and overall quality of life.

Why it matters

Potential benefit: If successful, this therapy could significantly improve swallowing function and quality of life for patients with neurogenic dysphagia.

How similar studies have gone: Other studies have shown positive outcomes with pharyngeal electrostimulation, indicating that this approach is promising and not entirely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Neurogenic dysphagia

  * Ischaemic and haemorrhagic strokes
  * Infra- as well as supra-tentorial
  * Polyradiculitis
  * Parkinson's disease
  * Multiple sclerosis
  * Dementia
  * Traumatic brain injury
  * Post Covid-19 pat.
* patients over the age of 18.

Exclusion Criteria:

* Contraindication to nasogastric tube,
* Unstable cardiac or respiratory condition that does not allow the insertion of the Nasogastric tube
* Pacemakers
* Implanted defibrillators (ICD)
* Pregnant
* Breastfeeding women

(Caution: interfering signals may be visible in ECGs, \& EEGs with continuous recording).

Where it's running

  • University Clinic Tulln
    Tulln, Low Austria, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.